Pranil Chandra

Pranil Chandra has extensive work experience in the field of pathology and genomics. Pranil started their career at Long Beach Medical Center with a rotating internship from 2001 to 2002. Pranil then worked at NYU Langone Medical Center, where they served as a House Officer from 2002 to 2006 and later as a Fellow from 2006 to 2007. Pranil went on to work at MD Anderson Cancer Center as the Chief Fellow from 2007 to 2009.

In 2009, Pranil joined Great Lakes Pathologists, S.C. as a Pathologist and Medical Director, specializing in molecular diagnostics. Pranil was responsible for anatomic and clinical pathology and molecular pathology, including PCR-based tests, bone marrows, and flow cytometry.

Pranil's next role was at PathGroup, where they held various leadership positions. Pranil started as an Associate Medical Director of Molecular Pathology in 2011 and was later promoted to Director of Molecular Pathology Services from 2013 to 2015. In 2016, they served as the Assistant Vice President and Medical Director of Molecular Pathology and Genomic Medicine Services. From 2017 to 2022, they held the position of Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services. Currently, Pranil is the Senior Vice President and Chief Genomics Officer at PathGroup, where they provide medical and administrative leadership to molecular and genomic pathology services, as well as clinical pathology laboratory services.

Pranil Chandra pursued their education in various fields of study. In 1993, they attended Cornell University, where they obtained a Bachelor of Science degree. Following this, from 1997 to 2001, Chandra enrolled at the New York College of Osteopathic Medicine, where they earned a Doctor of Osteopathic Medicine (DO) degree, focusing on the field of medicine.

Afterward, Chandra entered the UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, undertaking a Fellowship Certification in Molecular Genetic Pathology. During this period from 2007 to 2009, they specialized in Oncologic Surgical Pathology and Molecular Genetic Pathology.

In terms of additional certifications, Chandra has successfully acquired certifications in Anatomic and Clinical Pathology, Hematopathology, and Molecular Genetic Pathology from the American Board of Pathology. However, specific details regarding the month and year of obtaining these certifications are not available.

Lastly, there is mention of Chandra's association with the NYU Grossman School of Medicine, but no further information regarding the degree or field of study is provided.